Indian innovation leads the fight against the pandemic

    2020-09-23T13:27:20+00:00September 18th, 2020|Analysis - India Global Business, India Inc Views - India Global Business|

    Necessity has been the mother of invention in the response to the COVID-19 pandemic, and nowhere is this more apparent than in India. With a clear focus on affordability and low cost, here is how frugal Indian innovations have taken the commercial route to aid the fight against pandemic.

      UK trials new antibody cocktail treatment for Covid-19

      2020-09-18T10:29:52+00:00September 18th, 2020|iGLOBAL, iWellness|

      The UK has begun human trials of a new antibody treatment for patients hospitalised with Covid-19. As part of the government-backed Randomised Evaluation of Covid-19 therapy (RECOVERY) Trials, monoclonal antibodies, or potent laboratory-made antibodies, will be given to about 2,000 patients in the coming weeks to see if they are effective against coronavirus. The Phase 3 open-label trial in patients hospitalised with Covid-19 will compare the effects of adding REGN-COV2 to the usual standard-of-care versus standard-of-care on its own.

        Birmingham, Sandwell, Solihull under strict Covid-19 curbs

        2020-09-15T09:12:48+00:00September 15th, 2020|iGLOBAL, iWellness|

        From Tuesday, Birmingham, Sandwell and Solihull – cities with a significant Global Indian representation – will fall under the government’s “areas of intervention”, with residents told not to meet with people from outside their households to control the spread of coronavirus.

          Oxford University biotech spinoff strikes Covid-19 vaccine India deal

          2020-09-09T14:09:20+00:00September 9th, 2020|iGLOBAL, News & Views|

          A Global Indian professor’s Oxford-based company revealed that its Indian partner, the Serum Institute of India (SIIPL), has begun trials of a novel virus-like particle (VLP) vaccine targeting Covid-19 which has the potential to offer a groundbreaking new approach to fighting the pandemic.